My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$KBH {{ '2016-10-06T20:28:39+0000' | timeago}} • Announcement

$KBH's BoD declared a quarterly cash dividend of $0.025 per share on the company's common stock, payable on November 17, 2016 to stockholders of record on November 3, 2016.

User Vishnu Beri {{ '2016-10-25T21:15:45+0000' | timeago}}

Apple ($AAPL) reported decline in sales and profits from comparable quarter last year, attributing the decline to announcement of iPhone 7/7s. Sales and profit are being guided higher for next quarter. Apple is a solid company and will continue to dominate tech and consumer electronics segment for a while. Personally, looks like there is little downside in this investment.

User Mark Collas {{ '2016-10-25T20:12:01+0000' | timeago}}

Waiting with fingers crossed for $AAPL’s fourth quarter earnings.

User RC xNair {{ '2016-10-25T17:04:47+0000' | timeago}}

Looking ahead to $AAPL earnings release later in the afternoon today? Gene Munster, analyst from Piper Jaffrey and the most respected authority for Apple, had this to say - "The second and slightly larger group of investors believe the tail of the iPhone 7 is irrelevant, and is betting that the iPhone 10th Anniversary will yield a jump in growth from flat to up ~15%."

User Carlton Davis {{ '2016-10-24T19:31:20+0000' | timeago}}

$COL agreed to buy $BEAV for $6.4 billion in cash and stock. Also Rockwell Collins reported higher 4Q16 earnings on growth in Government Systems and higher revenue in Information Management Services.

User Charles Elliston {{ '2016-10-24T19:15:21+0000' | timeago}}

Wow! What a buzz the $T-$TWX deal is making! Almost everyone from politicians to competitors have come out against this deal. Even Wall Street doesn’t seem to be too thrilled. Both stocks were down today.

$GRMN {{ '2016-10-26T13:32:14+0000' | timeago}} • Announcement

Technology company $GRMN reported a rise in 3Q16 earnings as four of its five business segments delivered double digit sales growth and increased profitability. Net income rose to $125.05MM or $0.66 per share from $119.3MM or $0.63 per share last year. Net sales grew 6% to $722.25MM. Pro forma EPS increased 47% to $0.75.

$NDAQ {{ '2016-10-26T13:29:43+0000' | timeago}} • Webcast

$NDAQ's data products revenues rose $6MM to $109MM in 3Q16, helped by revenues from the ISE and Nasdaq CXC acquisitions as well as higher audit collections. Listing Services revenues grew $2MM to $68MM, helped by higher revenues in the Nordics due to new company listings.

$MDLZ {{ '2016-10-26T13:25:26+0000' | timeago}} • Announcement

For the full year, $MDLZ expects organic revenue growth of approx. 1.6%.The company raised its full-year Adjusted EPS outlook to a growth of approx. 25%. Based on foreign exchange rates as of Oct. 21, there would be a negative translation impact on FY net revenue growth of approx. 4 percentage points and on FY Adjusted EPS of approximately $0.09.

$BIIB {{ '2016-10-26T13:23:22+0000' | timeago}} • Webcast

$BIIB's collaboration partner Eisai has stated their goal to start a Phase III trial for E2609. A $50MM milestone payment is expected to be triggered once the first patient is dosed in the trial. There is a potential chance they could dose the first patient by the end of 2016. The $50MM milestone was not considered in the mid-year 2016 R&D outlook.

$CMCSA {{ '2016-10-26T13:23:02+0000' | timeago}} • Webcast

In the advanced advertising area, $CMCSA has a full rollout of VOD dynamic ad insertion, which is becoming more effective. The company is testing linear addressable advertising in a number of markets which is working. $CMCSA is making progress in leveraging acquisitions and existing advertising capabilities and believes this is a growth business.